S&P 500 7,698.27 +1.71%
Nasdaq 25,815.79 +1.75%
S&P/TSX 36,313.09 +2.20%
Apple 352.87 +6.32%
Nvidia 203.47 −1.56%
Microsoft 554.25 +6.38%
Shopify 211.91 +5.85%
Royal Bank 292.61 +2.52%
CAD/USD 0.7156 +0.06%
LIVE · 14:35 ET
Market ClerkRecap
Wed Nov 4 · markets open3 signals today175 insider buys this week · $365.2MCIRO short report next: Nov 15The week ahead

KLRS

Kalaris Therapeutics, Inc.
NASDAQ · HEALTH CARE · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
2.13
+0.09 +4.15%
USD · close Nov 4

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

One year, everything drawn on

252 SESSIONS · DAILY CLOSES
128.164.621.07Aug 11 · 10-Q filed (Q2 2026)Aug 11 · 10-Q filed (Q1 2026)Mar 17 · 10-K filed (FY 2025)Mar 17 · 10-K filed (Q4 2025)Nov 12 · 10-Q filed (Q3 2025)Aug 11 · 10-Q filed (Q2 2025)Aug 11 · 10-Q filed (Q1 2025)Mar 17 · 10-K filed (FY 2024)Mar 17 · 10-K filed (Q4 2024)Nov 12 · 10-Q filed (Q3 2024)Nov 12 · 10-Q filed (Q2 2024)Nov 12 · 10-Q filed (Q1 2024)NOV 2025JAN 2026APRJULOCT
Insider buyInsider sellCongress buy, above the lineCongress sell, below10-K / 10-Q filedHOVER A MARKER FOR THE FILING
THE WORK ORDER · 2026-11-03
Shorts (latest report): 346K short · −47K last period
Every line of the math
84PASS

Congress is trading it

No STOCK Act disclosure names KLRS.

Insider activity

No open-market insider filings on KLRS.
Watch KLRS. Know when insiders buy.
One email the day a filing lands. Free.